Investor acquires Aleris

Investor acquires Aleris

Investor AB has signed an agreement to acquire health care and care
service provider Aleris Holding AB (“Aleris”) from EQT III for an
enterprise value of SEK 4.4 bn. Investor's net investment, considering
the existing ownership in EQT's funds and the external debt-financing,
will amount to approximately SEK 1.7 bn. After the closing of the
transaction, Aleris will be a subsidiary of Investor AB. 

Aleris is market leading in the Nordic countries and has developed a
strong platform for growth focusing on both privately and publicly
financed care and healthcare services. The group has around 5,000
employees and in 2009, the group reported sales of approximately SEK 3.9
bn. and EBITDA (pro forma) of approximately SEK 400 m.

“Aleris has a strong market position and solid development potential in
an industry that fits well into our ownership model and long-term
approach. We look forward to develop the company further together with
the management and the people in the organization whose commitment to
quality care is an important prerequisite,” says Börje Ekholm, President
and CEO of Investor.

Aleris' CEO Stanley Brodén comments: “We are very pleased that it was
Investor that acquired Aleris. They are financially stable, have good
knowledge about our industry and a long-term strategy that give us very
attractive opportunities to further strengthen our market position.
Together we will continue to develop Aleris as a successful company
providing first-class health care and care services.”

Investor has a solid track record of building companies within the
healthcare area, with holdings such as AstraZeneca, Gambro, Mölnlycke
Health Care, CaridianBCT, Swedish Orphan Biovitrum, Memira, Vårdapoteket
and Global Health Partners.

Investor's ownership in Aleris will amount to 97 percent of the capital
and Aleris' management will own the remaining share. The external debt,
which is non-recourse to Investor AB, is arranged by SEB and Swedbank.
The company will have a debt ratio of around 45 percent.

Subject to certain operating milestones being reached in 2010-2012, up
to a maximum of SEK 100 m. (in net present value) in a deferred earn-out
payment can be made to EQT III in 2013.

Aleris will be included in Operating Investments as a consolidated
subsidiary.

The acquisition is subject to approval from the relevant competition
authorities.

Press meeting
A press meeting in Swedish will be held today in Stockholm, July 2, at
10:00 a.m. CET, at Investor AB headquarters on Arsenalsgatan 8C with
Investor's President and CEO Börje Ekholm and Stanley Brodén, President
of Aleris.

Conference call
A conference call in English will be held today, July 2, at 12:30 p.m.
CET. To participate, dial +44 203 043 24 36, +1 866 458 40 87 or +46 8
505 598 53. You can also listen to the proceedings of the conference
call afterwards on-demand on Investor's website
www.investorab.com (http://www.investorab.com/)

For further information: 
Oscar Stege Unger, Head of Corporate Communications, Phone +46 8 614
2059, +46 70 624 2059
Magnus Dalhammar, Investor Relations Manager, Phone +46 8 614 2130, +46
73 524 2130